Brian Pearlman, MD
Internal Medicine · Dalton, GANPI 1528068384
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $148,055 of the $198,558 with a category attached, or 74.6%. 20 manufacturers reported payments, led by Gilead at 49.8% of the total. Reporting peaked in 2019 at $94,584 and has fallen 86.8% since, to $12,505 in 2025. Among internal medicine clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 263 payments — averaging $754.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$99K
- AbbVie$89K
- Mallinckrodt Hospital Products Inc.$6K
- Ipsen Biopharmaceuticals, Inc$1K
- Novo Nordisk$1K
- Siemens Medical Solutions USA, Inc.$1K
- plus $422 from 14 others
Across 23 payments — averaging $6069.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$105K
- Gilead$27K
- AbbVie$8K
What the payments were for
- Consulting fees$20,16810%
- Speaking & faculty fees$148,05575%
- Travel & lodging$25,39613%
- Food & beverage$4,9392%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 124 | $98,929 |
| AbbVie | 112 | $88,987 |
| Mallinckrodt Hospital Products Inc. | 6 | $6,480 |
| Ipsen Biopharmaceuticals, Inc | 1 | $1,350 |
| Novo Nordisk | 2 | $1,313 |
| Siemens Medical Solutions USA, Inc. | 2 | $1,077 |
| Pfizer | 1 | $128 |
| Tandem Diabetes Care, Inc. | 2 | $43 |
| Mirum Pharmaceuticals, Inc. | 1 | $33 |
| Merck | 2 | $28 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Boehringer Ingelheim | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Insulet Corporation | 1 | $20 |
| Shire North American Group Inc | 1 | $20 |
| Dexcom, Inc. | 1 | $18 |
| Corcept Therapeutics | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| Intercept Pharmaceuticals, Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$198,558 in reported general payments places this provider in the 95th percentile of 3,311 internal medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $9,911 |
| Losartan Potassium | 13 | $210 |
| Atorvastatin Calcium | 17 | $91 |
| Amlodipine Besylate | 11 | $84 |
| Lisinopril | 14 | $75 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $128 | $9,91116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,311 internal medicine providers in Georgia.
Other internal medicine in Dalton
- Pablo PerezDalton$16K
- Michael GibsonSmyrna$2.2M
- Eduard FatakhovAlpharetta$376K
- Tracey HenryAtlanta$305K
- Sharon TuckettVilla Rica$265K
- Ebon BourneMarietta$242K
- Jennifer WoehlerSavannah$207K
- Julian HutchinsGreensboro$201K
- Scott ParryAtlanta$162K
- Jennifer GilliganAtlanta$162K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.